Companies / Atea Pharmaceuticals, Inc.
Atea Pharmaceuticals, Inc.
Nasdaq: AVIRCIK 1593899BOSTON, MA
Financials · FY2021
Ownership
80.2M shares outstanding · as of Aug 10, 2026
Ownership
| Insiders | 3.25% | 2,605,527 |
| 10%+ / strategic | 9.74% | 7,810,000 |
| Institutions | 71.69% | 57,494,837 |
| Public float | 15.33% | 12,294,335 |
% of common shares outstanding (exact, from the latest cover-page filing). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.
Insiders 9
View all →| Insider | % of shares | Shares |
|---|---|---|
Corcoran AndreaSee Remarks | 1.03% | 823,576 |
Sommadossi Jean-PierreCEOPresident, CEO, and Chairman · Director | 0.96% | 767,830 |
Berger Franklin MDirector | 0.67% | 536,097 |
Hammond Janet MJChief Development Officer | 0.16% | 127,665 |
Horga Maria ArantxaChief Medical Officer | 0.12% | 96,086 |
Duncan Barbara GayleDirector | 0.12% | 92,350 |
Vavricka JohnChief Commercial Officer | 0.10% | 82,594 |
Foster WayneEVP, Chief Accounting Officer | 0.10% | 79,329 |
Kirsch Arthur SDirector | — | — |
Institutional holders 116
View all →| Holder | Value | % of shares |
|---|---|---|
| $40.55M | 10.87% | |
| $34.55M | 12.07% | |
| $32.33M | 8.67% | |
| $25.90M | 6.00% | |
| $15.09M | 5.27% | |
| $10.03M | 2.32% | |
| $9.41M | 2.18% | |
| $8.87M | 3.10% | |
| $7.68M | 2.06% | |
| $6.28M | 1.45% |
Activity
InsidersInstitutions
What insiders are doing in this stock (Form 4).| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Jan 31, 2026 | Sommadossi Jean-Pierre CEO | Other | Common Stock | $449.8K | -106K -18.49% | 467,830 0.58% of shares | low |
| Feb 3, 2026 | Sommadossi Jean-Pierre CEO | Exercise | Common Stock | $372.0K | +300K +64.13% | 767,830 0.96% of shares | low |
| Mar 11, 2026 | Corcoran Andrea Executive | Exercise | Common Stock | $74.4K | +60K +7.86% | 823,576 1.03% of shares | low |
| Jan 31, 2026 | Corcoran Andrea Executive | Other | Common Stock | $68.3K | -16K -2.07% | 763,576 0.95% of shares | low |
| Jan 31, 2026 | Horga Maria Arantxa Executive | Other | Common Stock | $68.1K | -16K -14.33% | 96,086 0.12% of shares | low |
| Jan 31, 2026 | Hammond Janet MJ Executive | Other | Common Stock | $59.9K | -14K -9.97% | 127,665 0.16% of shares | low |
| Jan 31, 2026 | Foster Wayne Executive | Other | Common Stock | $51.4K | -12K -13.26% | 79,329 0.10% of shares | low |
| Jan 31, 2026 | Vavricka John Executive | Other | Common Stock | $49.1K | -12K -12.29% | 82,594 0.10% of shares | low |
5%+ ownership events
Schedule 13D / 13G
| Filer | Stance | % of class |
|---|---|---|
| Vanguard Group Inc | Passive13G/A | — |
| BML Investment Partners, L.P. | Passive13G | — |
Securities
via CUSIP / OpenFIGI
| Symbol | Type | CUSIP |
|---|---|---|
| AVIR | — | 04683R106 |